Ben Palmer, PGY-2, discusses the ISCHEMIA trial and how it impacts both Cardiologists and medicine physicians. DISCLAIMER: This podcast is made by and for our internal medicine residents to enhance our educational experience. The content, while edited by residents, is not verified by host or speakers and we are not content experts on these topics. The content provided by this podcast is not intended and should not construe as medical advice and should not be used to diagnose or treat any medical condition.
Join Alex, Casey, and Lee across the street in learning about Platypnea, ALS, and Apolipoprotein diseases. DISCLAIMER: This podcast is made by and for our internal medicine residents to enhance our educational experience. The content, while edited by residents, is not verified by host or speakers and we are not content experts on these topics. The content provided by this podcast is not intended and should not construe as medical advice and should not be used to diagnose or treat any medical condition. All
Blake Funke, Chief at Vanderbilt teaches us about acquired hemophilia, mucor, and high-output heart failure. DISCLAIMER: This podcast is made by and for our internal medicine residents to enhance our educational experience. The content, while edited by residents, is not verified by host or speakers and we are not content experts on these topics. The content provided by this podcast is not intended and should not construe as medical advice and should not be used to diagnose or treat any medical condition. A
PGY-3 Vik Induru joins Casey and Alex to discuss two recent non-inferiority trials questioning the necessity of prolonged IV antibiotic courses (vs oral antibiotics) for infective endocarditis (POET trial) and bone and joint infections (OVIVA). Stick around for a bonus discussion of the groundbreaking pre-print results of RECOVERY trial for the treatment of COVID-19!